secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001607062-23-000434
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma enters $175K promissory note and $10M equity line with Coventry
-------------------------------------------------------------------------------

- Net proceeds $148,750 after $26,250 original issue discount; note matures March 2025.
- Note carries 10% interest, convertible upon default at 90% of lowest 20-day trading price.
- Equity line allows draw downs at 80% of lowest price over prior 10 business days; max $250K per draw.
- Coventry receives 125,000 commitment shares; registration statement to cover up to 1,126,954 shares.
- Draw downs limited to 200% of average daily dollar traded value; beneficial ownership cap 4.99%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706223000434/0001607062-23-000434-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706223000434/rgbp091823form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-23-000434

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer